Multiferon(R) Melanoma Article Accepted For Publication In Leading Cancer Journal

... Viragen, Inc.(Amex: VRA) and its majority-owned subsidiary, Viragen International, Inc.(OTC Bulletin Board: VGNI), today announced that Acta Oncologica, a leadingjournal in clinical oncology, has accepted to publish an article profilingMultiferon(R) (multi-subtype, natural human alpha interferon) in the adjuvanttreatment of high-risk (Stages IIb-III) malignant melanoma... click link for more info. ...